Yarrow Bioscience (YARW) Common Equity (2016 - 2026)
Yarrow Bioscience's Common Equity was $22.06 million in Q2 2026, down 43.3% from $38.88 million a year earlier and down 10.5% from the prior quarter.
Powered by 
Analysis
Yarrow Bioscience (YARW) Common Equity (2016 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Yarrow Bioscience came in at $27.77 million, down 46.7% from FY2024.
- Common Equity shows a five-year compound annual growth rate of -5.8% (FY2020 to FY2025).
- In earlier years, Common Equity was $52.09 million in FY2024 (-41.3%), $88.74 million in FY2023 (+184.4%), $31.2 million in FY2022 (-35.8%) and $48.64 million in FY2021 (+29.7%).
- The Q2 2026 figure marks the lowest quarterly Common Equity since Q3 2023.
- Compared with a year earlier, Common Equity has declined for three straight quarters, with growth averaging 26.0% over the last seven quarters.
- The best year-over-year quarter for Common Equity over five years was Q3 2024 (growth of 452.3%); the worst was Q3 2023 (a decline of 71.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.96 Bn | 1,103.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 616.51 Bn | 535.04 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 501.10 Bn | 474.21 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 367.09 Bn | 321.47 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.10 Bn | 262.09 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.72 Bn | 235.40 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 235.73 Bn | 191.13 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 190.64 Bn | 164.84 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 169.63 Bn | 116.28 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Yarrow Bioscience | 17.12 Mn | -99.39 Mn | - | 22.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.06 Mn |
| Mar 31, 2026 | 24.64 Mn |
| Dec 31, 2025 | 27.77 Mn |
| Jun 30, 2025 | 38.88 Mn |
| Mar 31, 2025 | 44.13 Mn |
| Dec 31, 2024 | 52.09 Mn |
| Sep 30, 2024 | 63.54 Mn |
| Jun 30, 2024 | 74.87 Mn |
| Mar 31, 2024 | 83.37 Mn |
| Dec 31, 2023 | 88.74 Mn |
| Sep 30, 2023 | 11.51 Mn |
| Jun 30, 2023 | 17.27 Mn |
| Mar 31, 2023 | 26.43 Mn |
| Dec 31, 2022 | 31.20 Mn |
| Sep 30, 2022 | 40.07 Mn |
| Jun 30, 2022 | 48.36 Mn |
| Mar 31, 2022 | 55.73 Mn |
| Dec 31, 2021 | 48.64 Mn |
| Sep 30, 2021 | 58.89 Mn |
| Jun 30, 2021 | 74.89 Mn |
API Access
Yarrow Bioscience Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=YARW&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "YARW", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=YARW&period=max&api_key=YOUR_API_KEY");
const data = await res.json();